Overview
Aortic arch defects (also known as aortic arch anomalies or aortic arch malformations) encompass a group of congenital cardiovascular malformations affecting the aortic arch, which is the curved portion of the main artery that carries oxygenated blood from the heart to the rest of the body. These defects arise from abnormal development of the pharyngeal arch arteries during embryogenesis and include conditions such as interrupted aortic arch, double aortic arch, right aortic arch, cervical aortic arch, and coarctation of the aorta. The aortic arch is critical for delivering blood to the head, neck, arms, and the descending aorta supplying the rest of the body, so malformations can have significant hemodynamic consequences. Clinical presentation varies depending on the specific type and severity of the defect. Interrupted aortic arch, one of the most severe forms, typically presents in the neonatal period with signs of cardiovascular collapse, poor perfusion, and heart failure once the ductus arteriosus closes. Vascular ring anomalies such as double aortic arch may cause compression of the trachea and esophagus, leading to stridor, difficulty breathing, dysphagia, and recurrent respiratory infections. Some milder forms, such as certain right aortic arch variants, may be asymptomatic and discovered incidentally. Aortic arch defects may occur in isolation or in association with other congenital heart defects, and some are strongly associated with chromosomal abnormalities, particularly 22q11.2 deletion syndrome (DiGeorge syndrome). Treatment is primarily surgical and depends on the specific anomaly. Neonates with interrupted aortic arch require urgent surgical repair, often with prostaglandin E1 infusion to maintain ductal patency prior to surgery. Vascular rings typically require surgical division to relieve airway and esophageal compression. Coarctation of the aorta may be treated surgically or with catheter-based interventions. Long-term follow-up with a cardiologist is essential, as patients may develop complications such as re-coarctation, hypertension, or aneurysm formation. Genetic counseling is recommended, especially when associated syndromic features are present.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
3 eventsAssiut University
Beijing Anzhen Hospital
McGill University Health Centre/Research Institute of the McGill University Health Centre
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Aortic arch defects.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Aortic arch defects at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Aortic arch defects.
Community
No community posts yet. Be the first to share your experience with Aortic arch defects.
Start the conversation →Latest news about Aortic arch defects
Disease timeline:
New recruiting trial: NIRS in Congenital Heart Defects - Correlation With Echocardiography
A new clinical trial is recruiting patients for Aortic arch defects
New recruiting trial: An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease
A new clinical trial is recruiting patients for Aortic arch defects
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Aortic arch defects
What is Aortic arch defects?
Aortic arch defects (also known as aortic arch anomalies or aortic arch malformations) encompass a group of congenital cardiovascular malformations affecting the aortic arch, which is the curved portion of the main artery that carries oxygenated blood from the heart to the rest of the body. These defects arise from abnormal development of the pharyngeal arch arteries during embryogenesis and include conditions such as interrupted aortic arch, double aortic arch, right aortic arch, cervical aortic arch, and coarctation of the aorta. The aortic arch is critical for delivering blood to the head,
At what age does Aortic arch defects typically begin?
Typical onset of Aortic arch defects is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Aortic arch defects?
9 specialists and care centers treating Aortic arch defects are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.